Highly purified, Escherichia coli-derived recombinant human tumor necrosis factor (TNF) was labeled with 1251 and employed to determine receptor binding, internalization, and intracellular degradation in murine L929 cells (highly sensitive to the cytotoxic action of TNF) and in diploid human FS-4 cells (resistant to TNF cytotoxicity). 1251-labeled TNF bound specifically to high-affinity receptors on both L929 and FS-4 cells. Scatchard analysis of the binding data indicated the presence of 2200 binding sites per L929 cell and 7500 binding sites per FS-4 cell. The calculated dissociation constants are 6.1 x 10-10 M and 3.2 x 10-10 M for L929 and FS-4 cells, respectively. In both L929 and FS-4 cells, incubation at 370C resulted in a rapid internalization of the bulk of the cell-bound TNF, followed by the appearance of trichloroacetic acid-soluble 125I radioactivity in the tissue culture medium, due to degradation of TNF. Degradation but not cellular uptake of TNF was inhibited in the presence of chloroquine (an inhibitor of lysosomal proteases) in both L929 and FS-4 cells, suggesting that degradation occurs intracellularly, probably within lysosomes. These results show that resistance of FS-4 cells to TNF cytotoxicity is not due to a lack of receptors or their inability to internalize and degrade TNF.Tumor necrosis factor (TNF) was originally described as a protein found in the serum of animals sensitized with Bacillus Calmette-Guerin or Corynebacterium parvum and challenged with bacterial endotoxin (1). TNF is functionally defined as a protein producing hemorrhagic necrosis of some tumors in experimental animals and cytolytic or cytostatic effects in tumor cells in culture. Since the major cellular source of TNF is the macrophage (1-6), TNF is thought to be a mediator of the cytotoxic activity of macrophages against tumor cells (7). Recently, human TNF was purified to homogeneity (8) and cDNA for human TNF was cloned, sequenced, and expressed in Escherichia coli (9-11). As a result of these advances, highly purified recombinant TNF has become available for experimental'studies.One of the most intriguing properties of TNF is the apparent selectivity of its cytotoxic and cytostatic activities. TNF is active against many types of tumor cells, whereas untransformed cells generally remain unaffected (1, 11). The mechanism of this selectivity as well as the mechanisms by which TNF exerts its cytolytic or cytostatic activity are unknown. The action of polypeptide hormones, growth factors, and cytokines is generally initiated by their binding to specific cellular receptors (12). This binding is usually followed by internalization of the receptor-ligand complex, through receptor-mediated endocytosis, and the eventual degradation of the ligand by lysosomal hydrolases (13).In this study we examined the presence of high-affinity receptors on two cell lines-one highly sensitive (L929) and one completely resistant (FS-4)